•  
  • Home >> Featured Data >> Content
  • Research Report on Traditional Chinese Medicine Industry & Market of China
    Order ID:  CDC-R-2002-017
    ISBN:  2001 Version
    Publisher:  All China Marketing Research Co. Ltd.
    Publication Date:  6/1/2001 12:00:00 AM
    Format:  Paper Copy
    Languages:  English
    Pages:  88+
    Price:  $800 (for academic users)
    Notes:  
    Delivery:  Airmail
    Product Demo:  
    Sample Data:  
    URL:  
  • Description:  
    Preface This report, on the basis of a great deal of information, analyzes the management, trends, import and export, laws and regulations, listed companies and other aspects of Chinese patent drug industry, especially the production and operation of Chinese patent drug companies. It is expected to help readers to have a general understanding of Chinese patent drug industry of China.
    Table of Contents:  
    Content 1. Industry Production 1.1. Products 1.1.1. Definition 1.1.2. General Classification of Chinese patent drug 1.1.3. An Introduction of the Grouping Management of Drugs in China 1.2. Production 1.2.1. Output and Product Structure (on the basis of fourteen categories) 1.2.2. Output Value and Regional Distribution 1.2.3. Productive Capacity and Development Capacity 1.2.4. Supply of Raw Materials 1.2.5. Overall Situation 1.2.6. Major Production Bases 1.2.7. Problems in the Supply of Raw Materials 2. Enterprises 2.1. The Total Number of Enterprises 2.2. Enterprise Quantity and Ind 2.3. Ustry Economy 2.4. The System of Ownership 2.5. Regional Distribution of Enterprises 2.6. China's Top Fifty Enterprises in Sales Revenue in 2000 2.7. GMP Certification 3. Group Analysis of Enterprises 3.1. Group Analysis of Enterprises Divided on the Basis of Sales revenue 3.1.1. Introduction 3.1.2. Analysis 3.2. Group Analysis of Enterprises divided on the Basis of Ownership 3.2.1. Introduction 3.2.2. Analysis 3.2.3. The Ownership and Per Capita Profit 3.3. Listed Companies in Traditional Chinese Drug Industry 3.4. Conclusion of the Group Analysis 4. Import and Export 4.1. Export 4.1.1. Export Volume 4.1.2. The Export Destination Countries 4.1.3. The Change in the Export Volume of Chinese Patent Drug 4.1.4. The Composition of Traditional Chinese Drug export 4.1.5. The Problems in the Export of Traditional Chinese drug 4.1.6. The Factors Against the Export of Traditional Chinese Drugs 4.1.7. The Factors in Favor of the Export of Traditional Chinese Drug 4.2. Import 4.2.1. The Composition of Traditional Chinese Drug Import 4.2.2. The Countries That Export Traditional Chinese Drug to China in 2000 5. Management and Policy 5.1. An Introduction of the Organizing Structure and Function of major Administrative Departments of TCM Management in China 5.2. The Policies, Laws and Regulations in the Field of Drug Production 5.2.1. On the Supervision and Management of Drug Quality 5.2.2. On The Management of Drug production 5.2.3. An Brief Introduction of the Social Medical Security System of China 5.2.4. An Introduction to the List of Drugs under the Medical Insurance System 5.2.5. An Introduction of the Traditional Chinese Drug Protection System 5.2.6. The Tenth Five-year Plan Concerning Traditional Chinese Drug 6. Chinese Patent Drug Market 6.1. The Scale of Market in 1998 6.2. Market Shares in 1998 6.3. The Distribution Channel, Classification and Expected Growth of Drugs 6.4. China's Top Ten Chinese Patent Drugs and the Manufacturing Enterprises 6.5. Drugs Sold in Hospitals 6.6. The Change and Current Situation of the Composition of Inpatients, and the Impact of the Composition on the Market of Traditional Chinese drugs 6.7. The Practice of Hospitals Inviting Bids for the Sales of Drug 6.8. The Reform of Drug Circulation System and Drug Chain Operation 7. Main Trends in the Medical Industry 7.1. Drug Price Reduction 7.2. Resource Restructuring 7.3.The Modernization of Traditional Chinese Drug 8. Market Prediction 9. Conclusion and Advice 9.1. Conclusion 9.2. A Few Pieces of Advice 10. Introduction of Representative Enterprises Appendix 1, some main indices of Tongrentang, 1998-1999 Appendix 2, some main indices of Guangzhou Pharmaceutical Company, 1999-2000 Appendix 3, some main indices of Kunming Pharmaceutical Company, 1999-2000 Table Table 1 Fourteen categories as percentages of total output Table 2 China' top fifty enterprises in sales revenue, 2000 Table 3 The economic returns of enterprises of various ownerships in Chinese patent drug industry, 1999 Table 4 Listed companies in traditional Chinese drug industry on Shanghai and Shenzhen Stock Exchange Market Table 5 The return on each share of listed companies in Chinese patent drug industry, 2000 Table 6 Growth analysis Table 7 Analysis on the profit-making ability Table 8 Analysis on operation efficiency Table 9 Analysis on capital structure and debt paying ability Table 10 An introduction of the organizing structure and function of the administrative departments of TCM management of China Table 11 The surface demand of traditional Chinese drug market Table 12 Market shares of medicinal products and traditional Chinese medicinal products, 1998 Table 13 The distribution, classification and expected growth of drugs Table 14 China's top ten Chinese patent drugs and the manufacturing enterprises Table 15 The top ten diseases suffered by inpatients in city hospitals of the Ministry of Public Health of China Table 16 The top ten diseases suffered by inpatients in county hospitals of the Ministry of Public Health of China Figure Figure 1 The output and growth rate of Chinese patent drug, 1995-2000 Figure 2 Fourteen categories as percentages of total output ,1999 Figure 3 Fourteen categories as percentages of total output, 2000 Figure 4 The output value and growth rate, 1995-2000 Figure 5 The output value of Chinese patent drug as percentage of that of the medical industry Figure 6 The regional distribution of the annual output value of Chinese patent drug, 1999 Figure 7 The output and utility rate of productive capacity of fourteen categories, 1998-1999 Figure 8 Colleges and research institutions of traditional Chinese medicine Figure 9 The quantity of Chinese patent drug enterprises as the percentage of pharmaceutical industry Figure 10 The quantity and percentage of enterprises of various scales Figure 11 The percentage of output value and quantity of enterprises of various scales Figure 12 Enterprises of various ownership as percentages of the total Chinese patent drug enterprises, 1995-1999 Figure 13 The quantity of enterprises of various ownership in Chinese patent drug industry, 1995-1999 Figure 14 Regional distribution of enterprises in Chinese patent drug industry, 2000 Figure 15 The composition of enterprises to be analyzed Figure 16 The quantity of enterprises in various groups Figure 17 Total sales revenue of enterprises in each group Figure 18 The sales distribution by group Figure 19 The profit of each group Figure 20 The profit rate of each group Figure 21 The per capita profit of each group Figure 22 The asset profit rate of each group Figure 23 The quantity and proportion of earning enterprises and losing enterprises in each group Figure 24 Some other ratios Figure 25 The per capita sales revenue of enterprises of various ownership Figure 26 The per capita profit of enterprises of various ownership Figure 27 The composition of traditional Chinese drug export, 1994-1998 Figure 28 Main destination countries of traditional Chinese drug export and their percentages in the total export volume, 2000 Figure 29 The composition of traditional Chinese drug export, 1998 Figure 30 The composition of traditional Chinese drug import Figure 31 The countries that export traditional Chinese drug to China and their percentages Figure 32 The sales rates of some medical products, 1995-1999 Figure 33 The output and sales rate of Chinese patent drug, 1995-1999
China Data Center,330 Packard Rd, Ann Arbor, MI 48106-1248, T: (734)647-9610:F: (734)763-0335; Email: chinadata@umich.edu  Admin